New View Surgical develops the VisionPort™ System, a disposable surgical imaging and access device that combines multiple imaging and access functions into a single instrument for minimally invasive laparoscopic procedures. The VisionPort is designed to reduce the need for a separate camera port and camera holder and can eliminate the need for a separate team member to manage a laparoscope. The system is intended for a broad range of diagnostic and therapeutic procedures within the thoracic and abdominal cavities and is adaptable to a variety of surgical environments. The company says the device can lower capital and recurring equipment costs and make minimally invasive surgery more accessible in emerging markets. To fund commercialization and a limited market release, New View closed a $12.1M Series B-1 equity financing. The company expects to launch the VisionPort in the US before the end of 2022. New View Surgical is an emerging medical device company commercializing the VisionPort™ System, a novel imaging and access platform that combines multiple imaging and access devices into one disposable unit. The VisionPort System simplifies laparoscopic procedures by reducing the need for a separate camera port and camera holder and enables multiple simultaneous views of the operative field. The device is intended for a broad range of diagnostic and therapeutic procedures within the thoracic and abdominal cavities and is adaptable to a variety of surgical environments. In emerging markets the system is designed to reduce the capital-intensive equipment currently required for minimally invasive surgery, increasing accessibility. The company received FDA clearance for the VisionPort System in June and has initiated steps for initial market release. New View Surgical recently closed a $9M Series B to fund that market release and has expanded its board as it commercializes the platform. New View Surgical is an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery. Its initial product, the VisionPort System, is a novel surgical imaging and access system that aims to simplify laparoscopic procedures by reducing the need for a separate camera port and camera holder and by allowing multiple simultaneous views of the operative field. The VisionPort combines multiple imaging and access devices into a single, easy-to-use disposable device that the company says will deliver clinical and economic advantages. New View will use the $2.5 million Series A to complete development of the VisionPort System, expand its intellectual property portfolio, and submit a 510(k) filing with the U.S. Food and Drug Administration. The company says the device can reduce capital equipment needs in emerging markets, increase access to minimally invasive techniques, and improve operating room efficiency for surgeons and hospitals.

Total raised

$24M

Funding rounds

3

Latest round

Series B

Latest activity

Nov 2022